Stock listing
Frankfurt:5DG Ocumension Therapeutics Aktie
German listing (Frankfurt) of Ocumension Therapeutics · home listing HKEX:1477
Follow Ocumension Therapeutics into a list and get an email when it puts out news.
Share price · FWB:5DG
€0.515 EUR +0.021 (+4.3%)
Close on Oct 30, 2026
- Day range
- €0.515 – €0.515 EUROct 30, 2026
- Market cap
- €411.5M EURAt the close on Oct 30, 2026 · price × 799.0M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1477 · Home | $4.825 HKD | +0.035 (+0.7%) | 78,451 | $4.555 | $4.87 | $4.555 | $4.79 | Close on Nov 2, 2026 |
| Frankfurt:5DG | €0.515 EUR | +0.021 (+4.3%) | — | €0.515 | €0.515 | €0.515 | €0.494 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:5DG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Voluntary announcement nmpa approval for localized production of fluocinolone acetonide intravitreal implant
Latest news
Decks
Investor Presentation (January 2023)
Investor deck · 28 slides · January 2023
Ocumension Therapeutics on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 4 in the last 12 months · 25 in all · newest Oct 27, 2026 · oldest 2020
- Decks
- 1 deck · latest January 2023
Where Ocumension Therapeutics is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1477 歐康維視生物 · Home listing | HKEX | Hong Kong | HKD |
| LS Exchange:A2P723 | LS Exchange | Germany | EUR |
| gettex:5DG | gettex | Germany | EUR |
| Frankfurt:5DG · This page | Frankfurt | Germany | EUR |
| OTC:OCUTF | OTC | United States | USD |
| Dusseldorf:5DG | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A2P723 | Lang & Schwarz | Germany | EUR |
| Munich:5DG | Munich | Germany | EUR |
| Stuttgart:5DG | Stuttgart | Germany | EUR |
| Tradegate:5DG | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Ocumension Therapeutics.